This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Ryanair drops appeals of Covid aid programs to TAP, Finnair, Aegean Airlines, EU court documents show

( January 2, 2024, 14:18 GMT | Official Statement) -- MLex Summary: Ryanair has abandoned its legal challenges of national aid programs to the benefit of Transportes Aéreos Portugueses, Finnair and Aegean Airlines, according to EU General Court orders recently published. The Irish budget airline decided to discontinue its appeals of three Portuguese measures in favor of TAP, namely: a 107.1 million-euro support plan, a 71.4 million-euro damages program, and a 462 million-euro measure to compensate it for Covid-related losses. In addition, Ryanair decided to drop its legal challenge of a Greek government grant of 120 million euros to Aegean Airlines, as well as Finland's hybrid loan worth 351.4 million euros in favor of Finnair, which were also meant to compensate those airlines during the pandemic.The court orders are attached. Case references are T-164/22, T-185/22, T-340/21, T-444/21, T‑499/21....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections